Ablation versus anti-arrhythmic therapy for reducing all hospital episodes from recurrent atrial fibrillation: a prospective, randomized, multi-centre, open label trial
Europace (London, England), 2023-03, Vol.25 (3), p.863-872 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. 2022 ;The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. ;ISSN: 1099-5129 ;EISSN: 1532-2092 ;DOI: 10.1093/europace/euac253 ;PMID: 36576323
Full text available